Top

European Radiology

Published in:

01-05-2012 | Gastrointestinal

Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis

Authors: Perry J. Pickhardt, Seong Ho Park, Luke Hahn, Sung-Gyu Lee, Kyongtae T. Bae, Eun Sil Yu

Published in: European Radiology | Issue 5/2012

Abstract

Objectives

To determine a highly specific liver attenuation threshold at unenhanced CT for biopsy-proven moderate to severe hepatic steatosis (≥30% at histology).

Methods

315 asymptomatic adults (mean age ± SD, 31.5 ± 10.1 years; 207 men, 108 women) underwent same-day unenhanced liver CT and ultrasound-guided liver biopsy. Blinded to biopsy results, CT liver attenuation was measured using standard region-of-interest methodology. Multiple linear regression analysis was used to assess the relationship of CT liver attenuation with patient age, gender, BMI, CT system, and hepatic fat and iron content.

Results

Thirty-nine subjects had moderate to severe steatosis and 276 had mild or no steatosis. A liver attenuation threshold of 48 HU was 100% specific (276/276) for moderate to severe steatosis, with no false-positives. Sensitivity, PPV and NPV at this HU threshold was 53.8%, 100% and 93.9%. Hepatic fat content was the overwhelming determinant of liver attenuation values, but CT system (P < 0.001), and hepatic iron (P = 0.035) also had a statistically significant independent association.

Conclusions

Unenhanced CT liver attenuation alone is highly specific for moderate to severe hepatic steatosis, allowing for confident non-invasive identification of large retrospective/prospective cohorts for natural history evaluation of incidental non-alcoholic fatty liver disease. Low sensitivity, however, precludes effective population screening at this threshold.

Key Points

• Unenhanced CT liver attenuation is highly specific for diagnosing moderate/severe hepatic steatosis.

• Unenhanced CT can identify large cohorts for epidemiological studies of incidental steatosis.

• Unenhanced CT is not, however, effective for population screening for hepatic steatosis.

Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628PubMedCrossRef

Browning JD, Szczepaniak LS, Dobbins R et al (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387–1395PubMedCrossRef

Byron D, Minuk GY (1996) Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 24:813–815PubMedCrossRef

Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMedCrossRef

Hilden M, Christoffersen P, Juhl E et al (1977) Liver histology in a ‘normal’ population–examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 12:593–597PubMedCrossRef

Kammen BF, Pacharn P, Thoeni RF et al (2001) Focal fatty infiltration of the liver: analysis of prevalence and CT findings in children and young adults. AJR Am J Roentgenol 177:1035–1039PubMed

Park SH, Jeon WK, Kim SH et al (2006) Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 21:138–143PubMedCrossRef

Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231PubMedCrossRef

Dunn W, Xu R, Wingard DL et al (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103:2263–2271PubMedCrossRef

10.

Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923PubMedCrossRef

11.

Ong JP, Pitts A, Younossi ZM (2008) Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 49:608–612PubMedCrossRef

12.

Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49:306–317PubMedCrossRef

13.

Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474PubMedCrossRef

14.

Hourigan LF, Macdonald GA, Purdie D et al (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29:1215–1219PubMedCrossRef

15.

Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321PubMedCrossRef

16.

Petta S, Camma C, Di Marco V et al (2011) Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Liver Int 31:507–515PubMedCrossRef

17.

Selzner M, Clavien PA (2001) Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105–113PubMedCrossRef

18.

Angulo P (2010) Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51:373–375PubMedCrossRef

19.

Angulo P (2011) Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology 53:1792–1794PubMedCrossRef

20.

Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121PubMedCrossRef

21.

Dam-Larsen S, Franzmann M, Andersen IB et al (2004) Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53:750–755PubMedCrossRef

22.

Ekstedt M, Franzen LE, Mathiesen UL et al (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44:865–873PubMedCrossRef

23.

Teli MR, James OF, Burt AD, Bennett MK, Day CP (1995) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714–1719PubMedCrossRef

24.

McKimmie RL, Daniel KR, Carr JJ et al (2008) Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 103:3029–3035PubMedCrossRef

25.

Chalasani N, Wilson L, Kleiner DE et al (2008) Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 48:829–834PubMedCrossRef

26.

Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312PubMedCrossRef

27.

Lee SS, Park SH, Kim HJ et al (2010) Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 52:579–585PubMedCrossRef

28.

Park SH, Kim PN, Kim KW et al (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112PubMedCrossRef

29.

Park YS, Park SH, Lee SS et al (2011) Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Radiology 258:760–766PubMedCrossRef

30.

Speliotes EK, Massaro JM, Hoffmann U et al (2008) Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23:894–899PubMedCrossRef

31.

LeSage GD, Baldus WP, Fairbanks VF et al (1983) Hemochromatosis: genetic or alcohol-induced? Gastroenterology 84:1471–1477PubMed

32.

Strauss S, Gavish E, Gottlieb P et al (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 189:W320–323PubMedCrossRef

33.

Guiu B, Loffroy R, Cercueil JP et al (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification. Radiology 249:1081PubMedCrossRef

34.

Hines CD, Frydrychowicz A, Hamilton G et al (2011) T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 33:873–881PubMedCrossRef

35.

Meisamy S, Hines CD, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767–775PubMedCrossRef

36.

Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67–76PubMedCrossRef

37.

Fischer MA, Gnannt R, Raptis D et al (2011) Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol 46:351–358PubMedCrossRef

38.

Bydder GM, Kreel L, Chapman RW et al (1980) Accuracy of computed tomography in diagnosis of fatty liver. Br Med J 281:1042PubMedCrossRef

39.

Piekarski J, Goldberg HI, Royal SA et al (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729PubMed

40.

Kim DY, Park SH, Lee SS et al (2010) Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol 20:359–366PubMedCrossRef

41.

Lee SW, Park SH, Kim KW et al (2007) Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 244:479–485PubMedCrossRef

42.

Limanond P, Raman SS, Lassman C et al (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280PubMedCrossRef

43.

Oliva MR, Mortele KJ, Segatto E et al (2005) Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30:37–43CrossRef

44.

Yoshimitsu K, Kuroda Y, Nakamuta M et al (2008) Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 28:678–684PubMedCrossRef

45.

Birnbaum BA, Hindman N, Lee J et al (2007) Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 242:109–119PubMedCrossRef

46.

Sande EP, Martinsen AC, Hole EO et al (2010) Interphantom and interscanner variations for Hounsfield units–establishment of reference values for HU in a commercial QA phantom. Phys Med Biol 55:5123–5135PubMedCrossRef

47.

Cakir B, Kirbas I, Demirhan B et al (2009) Fulminant hepatic failure in children: etiology, histopathology and MDCT findings. Eur J Radiol 72:327–334PubMedCrossRef

48.

Shakil AO, Jones BC, Lee RG et al (2000) Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci 45:334–339PubMedCrossRef

49.

Saadeh S, Younossi ZM, Remer EM et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745–750PubMedCrossRef

Title: Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis
Authors: Perry J. Pickhardt
Seong Ho Park
Luke Hahn
Sung-Gyu Lee
Kyongtae T. Bae
Eun Sil Yu
Publication date: 01-05-2012
Publisher: Springer-Verlag
Published in: European Radiology / Issue 5/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-011-2349-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis

Abstract

Objectives

Methods

Results

Conclusions

Key Points

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 5/2012

Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women

Sonoelastography of parotid gland tumours: initial experience and identification of characteristic patterns

Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients

Threshold-based prediction of the coagulation zone in sequential temperature mapping in MR-guided radiofrequency ablation of liver tumours

Interdependencies of aortic arch secondary flow patterns, geometry, and age analysed by 4-dimensional phase contrast magnetic resonance imaging at 3 Tesla

Diffusion tensor imaging applications in multiple sclerosis patients using 3T magnetic resonance: a preliminary study